Biodegradable injectable in situ forming drug delivery systems

被引:557
作者
Hatefi, A
Amsden, B [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
[2] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada
关键词
drug delivery; in situ setting polymers; thermoresponsive polymers; thermoplastics; thermosets; solvent precipitation; ionotropic gelation; photocrosslinking gelation;
D O I
10.1016/S0168-3659(02)00008-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The ability to inject a drug incorporated into a polymer to a localized site and have the polymer form a semi-solid drug depot has a number of advantages. Among these advantages is ease of application and localized, prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated for use in delivering a wide variety of drugs. In this article we introduce the various strategies that have been used to prepare in situ setting systems. and outline their advantages and disadvantages as localized drug delivery systems. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:9 / 28
页数:20
相关论文
共 168 条
[1]  
ALADHOV VY, 1996, BIOCONJ CHEM, V7, P209
[2]   Amphiphilic copolymers and their applications [J].
Alexandridis, P .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 1996, 1 (04) :490-501
[3]   POLY(ETHYLENE OXIDE)-POLY(PROPYLENE OXIDE)-POLY(ETHYLENE OXIDE) BLOCK-COPOLYMER SURFACTANTS IN AQUEOUS-SOLUTIONS AND AT INTERFACES - THERMODYNAMICS, STRUCTURE, DYNAMICS, AND MODELING [J].
ALEXANDRIDIS, P ;
HATTON, TA .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 1995, 96 (1-2) :1-46
[4]   A MIXED MICELLAR FORMULATION SUITABLE FOR THE PARENTERAL ADMINISTRATION OF TAXOL [J].
ALKANONYUKSEL, H ;
RAMAKRISHNAN, S ;
CHAI, HB ;
PEZZUTO, JM .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :206-212
[5]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[6]  
Allen C, 1999, STP PHARMA SCI, V9, P139
[7]   SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES - A COMPARISON WITH THE INTRAVENOUS AND INTRAPERITONEAL ROUTES OF INJECTION [J].
ALLEN, TM ;
HANSEN, CB ;
GUO, LSS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1150 (01) :9-16
[8]  
ANDERSON PM, 1992, J IMMUNOTHER, V12, P19
[9]  
[Anonymous], [No title captured], Patent No. [5, 252-318, 5252318]
[10]  
Anseth KS, 1995, ADV POLYM SCI, V122, P177